Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), October 2008
Sponsors and Collaborators: Gynecologic Oncology Group
National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00379145
Estimated Enrollment: 43
Study Start Date: June 2007
Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Investigators
Study Chair: Bradley J. Monk, MD Chao Family Comprehensive Cancer Center
Last Updated: October 22, 2008